TY - UNPB
T1 - Fair value versus historic cost Valuation for Biological assets: Implications for the quality of financial information
T2 - Documents de Treball de la Facultat d'Economia i Empresa
AU - Argiles-Bosch, Josep Maria
AU - Garcia Blandón, Josep
AU - Monllau, Teresa
PY - 2009
Y1 - 2009
N2 - This research finds neither significant differences in earnings and revenues for farms using fair value (FV) for biological assets with respect to those valuing at historic cost (HC), nor an increase in their volatility. It does not bring about differences in profitability, accounting manipulation and farm cash flows predictability either. On the contrary, most tests reveal higher predictive power of future earnings under FV. The study also provides evidence on flawed HC accounting practices in the agricultural sector and concludes that FV seems an interesting tool for the predominant small holdings in the agricultural sector in the European Union.
AB - This research finds neither significant differences in earnings and revenues for farms using fair value (FV) for biological assets with respect to those valuing at historic cost (HC), nor an increase in their volatility. It does not bring about differences in profitability, accounting manipulation and farm cash flows predictability either. On the contrary, most tests reveal higher predictive power of future earnings under FV. The study also provides evidence on flawed HC accounting practices in the agricultural sector and concludes that FV seems an interesting tool for the predominant small holdings in the agricultural sector in the European Union.
KW - Agricultural accounting
KW - Fair value
KW - Historic cost
KW - Biological assets
KW - Earnings prediction
KW - Cash flow prediction
KW - Accounting relevance
KW - Contabilidad agrícola
KW - Valor razonable
KW - Coste histórico
KW - Activos biológicos
KW - Predicción de beneficios
KW - Predicción de flujos de tesorería
KW - Relevancia contable
M3 - Working paper
SN - 1136-8365
SP - 1
EP - 26
BT - Fair value versus historic cost Valuation for Biological assets: Implications for the quality of financial information
CY - Barcelona, Espanya
ER -